A new research study has found that the protein DYRK1A, which is linked to Down Syndrome, can be inhibited, potentially leading to improved cognitive development. The study, conducted by scientists from the University of Cambridge, has revealed that DYRK1A is a key regulator of neuronal development in the brain, and that its inhibition could have a positive effect on cognitive function. The results of the study suggest that there may be potential therapeutic implications for individuals with Down Syndrome in the future. It is hoped that further research will shed more light on the role of DYRK1A in the development of the brain, and how inhibiting this protein could potentially improve the cognitive abilities of those with Down Syndrome.

Read Full Article Here

source: Phys.org